These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 16522659)
1. Vascular diseases and their risk factors in IgA nephropathy. Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659 [TBL] [Abstract][Full Text] [Related]
2. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382 [TBL] [Abstract][Full Text] [Related]
3. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258 [TBL] [Abstract][Full Text] [Related]
4. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854 [TBL] [Abstract][Full Text] [Related]
5. Factors predicting progression of IgA nephropathies. Coppo R; D'Amico G J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675 [TBL] [Abstract][Full Text] [Related]
6. Presentation, prognosis and outcome of IgA nephropathy in Indian adults. Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102 [TBL] [Abstract][Full Text] [Related]
7. Clinical features and natural history of IgA nephropathy. Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260 [TBL] [Abstract][Full Text] [Related]
8. [Renal vascular lesions and the occurrence of hypertension in patients with IgA nephropathy]. Boulahrouz R; Stanescu C; Charasse C; Ang KS; Le Cacheux P; Leonetti F; Rioux N; Ramee MP; Simon P Arch Mal Coeur Vaiss; 2004; 97(7-8):782-5. PubMed ID: 15506066 [TBL] [Abstract][Full Text] [Related]
9. Clinical course and prognostic factors of clinical early IgA nephropathy. Shen P; He L; Huang D Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907 [TBL] [Abstract][Full Text] [Related]
10. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168 [TBL] [Abstract][Full Text] [Related]
11. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience. Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776 [TBL] [Abstract][Full Text] [Related]
12. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239 [TBL] [Abstract][Full Text] [Related]
13. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Wu J; Chen X; Xie Y; Yamanaka N; Shi S; Wu D; Liu S; Cai G Nephrol Dial Transplant; 2005 Apr; 20(4):719-27. PubMed ID: 15701667 [TBL] [Abstract][Full Text] [Related]
14. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586 [TBL] [Abstract][Full Text] [Related]
15. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study. Frimat L; Hestin D; Aymard B; Mayeux D; Renoult E; Kessler M Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966 [TBL] [Abstract][Full Text] [Related]
16. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy. Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649 [TBL] [Abstract][Full Text] [Related]
17. [Variable number of tandem repeats polymorphism of MUC20 is associated with the progression of IgA nephropathy]. Li GS; Zhang H; Lü JC; Hou P; Zhou Y; Ma XZ; Wang HY Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1333-8. PubMed ID: 16029633 [TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy. Peters HP; van den Brand JA; Wetzels JF Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and prognostic factors of asymptomatic IgA nephropathy. Shen PC; He LQ; Tang Y; Wang Q; Wang W; Li J J Investig Med; 2010 Mar; 58(3):560-5. PubMed ID: 20215916 [TBL] [Abstract][Full Text] [Related]
20. [A familial history of hypertension is associated with the development of hypertension and nephroangiosclerosis in patients with glomerulonephritis caused by mesangial IgA deposits]. Boulahrouz R; Autuly V; Charasse C; Le Cacheux P; Ang KS; Ramee MP; Simon P Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1065-8. PubMed ID: 8949380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]